Wednesday, 14 October 20268:11 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

¹²⁴I-evuzamitide PET/CT Shows Promise for Diagnosing Cardiac Amyloidosis: JAMA

Image: Business Medical Dialogues. Rights remain with the publisher.

USA: A new clinical trial has found that 124I-evuzamitide positron emission tomography/computed tomography (PET/CT) can accurately detect cardiac amyloidosis, demonstrating 94% sensitivity and 86%...

Read the full report on Business Medical Dialogues

Story file

Section
Health
First reported by
Business Medical Dialogues
Reporter
medha baranwal
Published
Wednesday, 14 October 2026, 6:00 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all